1. Gut Inflammation: More Than a Peripheral Annoyance

   • Marcus Gray
   • Gerald Holtmann

   Editorial 02 May 2017 Pages: 2205 - 2207

   

2. CD4 T Cells in IBD: Crossing the Line?

   • Elisa K. Boden
   • James D. Lord

   Editorial 23 June 2017 Pages: 2208 - 2210

   

3. NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?

   • Ling Liu
   • Xuhang Li

   Editorial 19 June 2017 Pages: 2211 - 2214

   

4. Obesity, Metabolic Syndrome, and Cardiac Risk Factors: Going Gluten-Free, for Better or Worse?

   • Louise Emilsson
   • Carol E. Semrad

   Editorial 21 June 2017 Pages: 2215 - 2216

5. Association of Helicobacter pylori and Crohn’s Disease Incidence: An Inversion Reaction?

   • Lars Erik Bartels
   • Jens Frederik Dahlerup

   Editorial 05 April 2017 Pages: 2217 - 2219

6. Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time?

   • Francesca Romana Ponziani
   • Maurizio Pompili
   • Antonio Gasbarrini

   Editorial 23 June 2017 Pages: 2220 - 2222

   

7. Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury

   • John L. Wallace
   • Angela Ianaro
   • Gilberto de Nucci

   Invited Review 21 July 2017 Pages: 2223 - 2230

   

8. Gastroparesis: Medical and Therapeutic Advances

   • Christopher M. Navas
   • Nihal K. Patel
   • Brian E. Lacy

   Invited Reviews 18 July 2017 Pages: 2231 - 2240

   

9. Sulfur Cycling and the Intestinal Microbiome

   • Larry L. Barton
   • Nathaniel L. Ritz
   • Henry C. Lin

   Review 01 August 2017 Pages: 2241 - 2257

   

10. Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger–Ellison Syndrome

    • Aaron H. Mendelson
    • Mark Donowitz

    Review 03 August 2017 Pages: 2258 - 2265

    

11. Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models

    • Fadi H. Mourad
    • Yunki Yau
    • Rupert W. Leong

    Review 17 July 2017 Pages: 2266 - 2276

12. Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis

    • Albert J. Czaja

    Review 14 July 2017 Pages: 2277 - 2292

    

13. Say What? Bannayan–Riley–Ruvalcaba Syndrome Presenting with Gastrointestinal Bleeding Due to Hamartoma-Induced Intussusception

    • William Kethman
    • Aarti Rao
    • Cindy Kin

    Stanford Multidisciplinary Seminars 06 February 2017 Pages: 2293 - 2297

    

14. Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?

    • Anas Gremida
    • Ahmad Al-Taee
    • Denis McCarthy

    UNM Clinical Case Conferences 07 August 2017 Pages: 2298 - 2302

    

15. Regional Variability of Repeat Esophagogastroduodenoscopy Use in the National Veteran Population

    • Andrew J. Gawron
    • Garrett Cole
    • Matthew Samore

    Original Article 31 July 2017 Pages: 2303 - 2310

    

16. Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012

    • Felipe Bellolio Roth
    • Javier Gómez
    • Jaime Cerda

    Original Article 30 June 2017 Pages: 2311 - 2317

    

17. Cost of Illness in Inflammatory Bowel Disease

    • Nagesh Kamat
    • C. Ganesh Pai
    • Asha Kamath

    Original Article 01 August 2017 Pages: 2318 - 2326

    

18. Impaired Interoception in a Preclinical Model of Functional Dyspepsia

    • John H. Winston
    • Jose E. Aguirre
    • Sushil K. Sarna

    Original Article Open access 29 March 2017 Pages: 2327 - 2337

    

19. Vitamin C Improves Gastroparesis in Diabetic Rats: Effects on Gastric Contractile Responses and Oxidative Stress

    • Luisa Mota Da Silva
    • Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva
    • Maria Fernanda de Paula Werner

    Original Article 21 June 2017 Pages: 2338 - 2347

    

20. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn’s Disease and Ulcerative Colitis

    • Lazaros-Dimitrios Lazaridis
    • Aikaterini Pistiki
    • Konstantinos Triantafyllou

    Original Article 18 May 2017 Pages: 2348 - 2356

    

21. Crossover Subsets of CD4⁺ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn’s Disease and Ulcerative Colitis

    • Ji Li
    • Aito Ueno
    • Subrata Ghosh

    Original Article 01 June 2017 Pages: 2357 - 2368

    

22. Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival

    • Zhongming Dai
    • Shufang Wang
    • Yunsheng Yang

    Original Article 01 August 2017 Pages: 2369 - 2375

    

23. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer

    • Chuan Liu
    • Xiaowei Fu
    • Yeqing Zou

    Original Article 23 June 2017 Pages: 2376 - 2385

    

24. The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy

    • Hideyuki Ogiso
    • Hiroyasu Ito
    • Mitsuru Seishima

    Original Article 21 June 2017 Pages: 2386 - 2396

    

25. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature

    • Silvia Fittipaldi
    • Francesco Vasuri
    • Antonia D’Errico

    Original Article 21 June 2017 Pages: 2397 - 2407

    

26. Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression

    • Cary C. Cotton
    • Swathi Eluri
    • Evan S. Dellon

    Original Article 12 June 2017 Pages: 2408 - 2420

    

27. Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk

    • Tomomitsu Tahara
    • Sayumi Tahara
    • Naoki Ohmiya

    Original Article 12 July 2017 Pages: 2421 - 2427

    

28. Latiglutenase Improves Symptoms in Seropositive Celiac Disease Patients While on a Gluten-Free Diet

    • Jack A. Syage
    • Joseph A. Murray
    • Chaitan Khosla

    Original Article 28 July 2017 Pages: 2428 - 2432

    

29. Application of the Biopsy-Sparing ESPGHAN Guidelines for Celiac Disease Diagnosis in Adults: A Real-Life Study

    • Konstantinos Efthymakis
    • Mariaelena Serio
    • Matteo Neri

    Original Article 17 July 2017 Pages: 2433 - 2439

    

30. Obesity, Metabolic Syndrome, and Cardiovascular Risk in Gluten-Free Followers Without Celiac Disease in the United States: Results from the National Health and Nutrition Examination Survey 2009–2014

    • Hyun-seok Kim
    • Michael F. Demyen
    • Sushil K. Ahlawat

    Original Article 27 April 2017 Pages: 2440 - 2448

    

31. Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet

    • Jocelyn A. Silvester
    • Lesley A. Graff
    • Donald R. Duerksen

    Original Article 07 July 2017 Pages: 2449 - 2454

32. Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

    • M. Pimentel
    • B. D. Cash
    • P. Schoenfeld

    Original Article Open access 06 June 2017 Pages: 2455 - 2463

33. Specialist Endoscopists Are Associated with a Decreased Risk of Incomplete Polyp Resection During Endoscopic Mucosal Resection in the Colon

    • Anna Tavakkoli
    • Ryan J. Law
    • Richard S. Kwon

    Original Article 09 June 2017 Pages: 2464 - 2471

    

34. Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?

    • Ayesha Shah
    • Nicholas J. Talley
    • Gerald Holtmann

    Original Article 09 March 2017 Pages: 2472 - 2480

    

35. Evolution of Clinical Behavior in Crohn’s Disease: Factors Associated with Complicated Disease and Surgery

    • Kátia Simone Cezário de Barros
    • Cristina Flores
    • Carlos Fernando Magalhães Francesconi

    Original Article 26 July 2017 Pages: 2481 - 2488

    

36. Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis

    • Eun Soo Kim
    • Kyeong Ok Kim
    • On behalf of Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD)

    Original Article 21 June 2017 Pages: 2489 - 2497

    

37. Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival

    • Duminda Subasinghe
    • Sivasuriya Sivaganesh
    • Menaka Dilani Samarwickrema Lokuhetty

    Original Article 13 June 2017 Pages: 2498 - 2510

    

38. BMI Is a Risk Factor for Colorectal Cancer Mortality

    • Aasma Shaukat
    • Allison Dostal
    • Timothy R. Church

    Original Article 21 July 2017 Pages: 2511 - 2517

    

39. Impact of Age on the Risk of Advanced Colorectal Neoplasia in a Young Population: An Analysis Using the Predicted Probability Model

    • Yoon Suk Jung
    • Chan Hyuk Park
    • Dong Il Park

    Original Article 21 July 2017 Pages: 2518 - 2525

    

40. Racial Disparities in Clinical Presentation and Survival Times Among Young-Onset Colorectal Adenocarcinoma

    • Hafiz Muhammad Sharjeel Arshad
    • Christopher Kabir
    • Hareth Raddawi

    Original Article 19 June 2017 Pages: 2526 - 2531

    

41. Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program

    • Ding Ye
    • Qiuchi Huang
    • Kun Chen

    Original Article 20 June 2017 Pages: 2532 - 2541

    

42. Simultaneous Versus Sequential Side-by-Side Bilateral Metal Stent Placement for Malignant Hilar Biliary Obstructions

    • Tadahisa Inoue
    • Norimitsu Ishii
    • Masashi Yoneda

    Original Article 01 August 2017 Pages: 2542 - 2549

    

43. A New Fully Covered Self-Expandable Metal Stent for the Treatment of Postsurgical Benign Biliary Strictures

    • Jun Wu
    • Dong-xun Zhou
    • Bing Hu

    Original Article 03 August 2017 Pages: 2550 - 2557

    

44. Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis

    • Philipp Lutz
    • Felix Goeser
    • Ulrich Spengler

    Original Article 09 June 2017 Pages: 2558 - 2568

    

45. Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan^®: A Comparative Study with the M Probe and Liver Biopsy

    • Victor de Lédinghen
    • Jean-Baptiste Hiriart
    • Valérie Paradis

    Original Article 02 June 2017 Pages: 2569 - 2577

    

46. High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation

    • Eliza W. Beal
    • Sylvester M. Black
    • Dmitry Tumin

    Original Article 01 June 2017 Pages: 2578 - 2585

    

47. Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma

    • Hyuk Soo Eun
    • Byung Seok Lee
    • Seok Hyun Kim

    Original Article 25 July 2017 Pages: 2586 - 2600

    

48. Rare Duodenal Varix Coil Erosion Post TIPS Creation and Coil Embolization of Mesenteric–Systemic Shunt

    • Matthew P. Soape
    • Andrew Lichliter
    • J. Steven Burdick

    Case Report 07 July 2017 Pages: 2601 - 2603

    

49. Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?

    • Alessandro Sartini
    • Stefano Gitto
    • Erica Villa

    Correspondence 04 July 2017 Pages: 2604 - 2606

50. Erratum to: The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting

    • N. A. Koloski
    • M. Jones
    • G. Holtmann

    Erratum 08 July 2017 Pages: 2607 - 2607